Article
Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.
Journal of viral hepatitis - 1 Mar 2015
Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan A B, Abdel-Hamid M, El-Daly M, Gamal M E, El Kassas M, Bedossa P, Carrat F, Fontanet A, Esmat G
Abstract excerpt
In Egypt, as elsewhere, liver biopsy (LB) remains the gold standard to assess liver fibrosis in chronic hepatitis C (CHC) and is required to decide whether a treatment should be proposed. Many of its disadvantages have led to develop noninvasive methods to replace LB. These new methods should be evaluated in Egypt, where circulating virus genotype 4 (G4), increased body mass index and co-infection with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.